Providing Natural, Science-Based Biological Solutions for High Value Crops

Corporate Presentation

May 2020April 2018

CSE: MGROOTC: MGROF

FRA: 0C0

The views expressed herein contain information derived from publicly available sources that have not been independently verified. No representation or warranty is made as to the accuracy, completeness or reliability of the information. This Presentation should not be relied upon as a recommendation or forecast by MustGrowBiologics Corp. (“MustGrow”).

Certain statements contained herein constitute forward-looking statements. The words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions are intended to identify forward-looking statements. Such statements reflect MustGrow's current views with respect to future events and are subject to certain risks, uncertainties and assumptions (known and unknown). Many factors could cause MustGrow's actual results, performance or achievements to vary from those described herein. Should one or more of these risks or uncertainties materialize, or should assumptions underlying forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, sought, proposed, believed, estimated or expected. MustGrow does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law.

Note that purchasing securities of MustGrow should be considered a risky investment as the securities are speculative in nature and are appropriate only for investors who are prepared to have their money invested for a long period of time and have the capacity to absorb a loss of some or all of their investment. There is no public market for the securities of MustGrow, and one may never develop, therefore investors may find it difficult to resell their securities.

The securities referred to in this Presentation have not been and will not be registered under the U.S. Securities Act of 1933 or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act of 1933 and any other applicable securities laws. This Presentation does not constitute an offer to sell, or the solicitation of an offer to buy, the securities, nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Disclaimer

2

About MustGrow

MustGrow Biologics Corp. (CSE: MGRO / OTC: MGROF / FRA: 0C0) is an agriculture bio-tech company focused on providing natural, science-based biological solutions to replace synthetic chemicals used in high value crops such as organic fruit & vegetables.

• Global chemistries are being banned or deregistered• Consumers demand food that is healthy, natural and safe.• Producers want to use safe products to protect their crops… but only if they work.

• 100% owned patented Mustard-Derived technology• Natural Bio-Pesticide that acts as a pre-plant treatment for soil-borne pests and diseases.• >110 independent trials confirming safety and efficacy• Compared to synthetic chemicals, we can compete on efficacy and potentially on price.• Natural Bio-Herbicide to potentially disrupt the ‘weed-killer’ spray market.

• Tight capital structure• 37MM shares outstanding with ~14MM free trading.• Management and advisors own 22% of total shares.• ~C$3.3MM in cash with ~C$13MM market cap.

3

MustGrow is primarily focused on disrupting the US$65 billion global pesticide market

|

Safe and Effective Natural Products

Management, Directors & AdvisorsCorey Giasson, MBA President, CEO & Director• ~25 years of agriculture experience with an MBA

and B.Sc. Ag Economics from the University of Saskatchewan

• Previous Co-founder & CEO of RallyemontEnergy, sold to Husky Energy

• Previous Vice President, at Anglo Potash, sold to BHP

4

Colin BletskyCOO & Director• ~30 years of experience in agriculture• Previous Vice President, BioAg at Novozymes

where he was responsible for the BioAg business worldwide

• Colin holds a Bachelor of Science in Agriculture from the University of Saskatchewan

Brad Munro – Chairman • 20+ years as a VP, Investments with a national venture capital firm where

he sourced, invested, and managed the activity of over 30 companies and invested $150MM

• Brad is currently a Director of Secure Energy Services

Brian Quigley – Director• Co-Founder of Green Sky Strategy• 16 years at Altria Group; including CEO of Altria’s innovation company

Matt Kowalski – Director• Director, VRM Labs• Past President & CEO and Natural Industries from 2002-2012• Previous Global Market Manager: Bio Control, Novozymes BioAg

Tom Flow – Director• Founder & Co-CEO of The Flowr Corporation• Previous Co-Founder of MedReleaf (sold for $3.2B)• Widely-recognised for cannabis cultivation thought leadership and

expertise

Jamieson Bondarenko – Capital Markets Advisor• Current: Advisor to Lexaria Bioscience Corp., Chairman of BriaCell

Therapeutics Corp.• Previous Equity Capital Markets roles with Eight Capital, Dundee,

HSBC

Mark Hetherington – Scientific & Formulations Advisor• Expert Director of Clinical Research in the Canadian cannabis

industry

Dr. David Maenz – Scientific & Production Advisor• Inventor or co-inventor of 7 patents• Expert in processing and extraction from oilseeds

World-class team of agriculture and business professionals

Todd Lahti, CFA, CPA CA CFO• +30 years of business experience in finance and

operating companies in a multitude of business sectors

• Has closed over 50 M&A, financing and licensing transactions totaling over $2.4 billion

• Previously President of MCN BioProducts Inc., an agricultural technology company, sold to Bunge Ltd. in 2012

How Has This Pesticide Not Been Banned?The pesticide known as chlorpyrifos is both clearly dangerous and in very wide use. It is known to pass easily from mother to fetus and has been linked to a wide range of serious medical problems, including impaired development, Parkinson’s disease and some forms of cancer. That’s not entirely surprising. The chemical was originally developed by Nazis during World War II for use as a nerve gas.-- The New York Times; December 17, 2019

Global Chemistries are Being Banned or Deregistered

Bayer says U.S. glyphosate plaintiffs more than double since JulyGermany’s Bayer is now facing 42,700 U.S. Plaintiffs blaming its glyphosate-based weedkillers for their cancer, more than twice the tally in July and potentially raising any future settlement.-- Reuters; October 30, 2019

France bans crop pesticide metam sodium after people fall illThe US Environmental Protection Agency (EPA) considers metam sodium a probable human carcinogen … Still, metam sodium is among the most widely used agricultural pesticides in the United States.-- Reuters; November 5, 2018

U.S. appeals court orders EPA to ban pesticide said to harm childrenJudge Jed Rakoff directed the EPA to ban chlorpyrifos within 60 days, saying the agency failed to counteract scientific evidence that its residue on food causes neurodevelopmental damage to children.-- Reuters; August 9, 2018

5

Biologics vs. Chemistries

6

Safe

Harmful

EffectiveNot Effective

• MustGrow is focused on providing natural, science-based biological solutions that are both safe AND effective to replace synthetic chemicals used in high value crops

• Crop producers want to use safe products to protect their crops… but only if they work

Biologics

Chemistries

Proven Pre-Plant Bio-Pesticide; Not a Chemistry

7

Nematode Control

Natural Mustard-Derived

Disease Control

100% Owned Patented Bio-Pesticide

>110 Independent Trials

Organic

New Liquid Formulation

“Granular Format” is already EPA-approved – Now seeking registration

for Liquid Formulation label

Safe & Effective

Liquid Formulation à EPA (US) and PMRA (Canada) estimated registration approval by Q1-2021

Value Proposition for Fruit & Vegetable Growers• MustGrow’s original granular technology had excellent efficacy but only modest market penetration

due to:• Bulky granular product that was costly to transport, therefore high end use price per acre• Fruit & vegetable growers prefer application through drip line and not via broadcast methods

• MustGrow’s Liquid Formulation (TerraMGTM) has great potential to compete on price compared to chemistries:• 2.5-5.0 gal/acre had 100% control of key soil based fungus.

• ~20% of U.S. crop acres are designated as buffer zones à acres near schools, farm yards, etc. where chemical crop inputs are not allowed... MustGrow will target these as well as all conventional acres

Source: Globenewire

8

Global: US$1.2B

Projected Global Fumigation Market (2025; 4.6% CAGR)

US: $504MM (42%) ~$50MM

Potential Revenue from 10% US Market Penetration

Massive Potential for Other Applications

9

$15 Billion$13 Billion

$18 Billion

$2B

$12 Billion

Grain Toxins$15B est global loss

Non Selective Herbicide $13B global market size

Container Fumigation

$2B est global market size

Bananas – Panama Disease$18B est global loss

E. coli, Salmonella & Listeria$12B est global loss

Fruit & Veg Soil Fumigation

$1.2B est global market size

Cannabis Soil Fumigation &

Powdery Mildew$200MM est market

size (Canada)

$4B

Tobacco Nematode & Disease Fumigation$4B est global loss

MustGrow testing completed and data confirmed

MustGrow testing in progress

Source: Globenewire

MustGrow’s Products Can Treat These Pests and Diseases

* MustGrow has in licensed a product to treat powdery mildew for cannabis and hemp in Canada. Note that this product was previously used in the Canadian cannabis hemp industry, but had cannabis and hemp removed from the label due to corporate reasons.

Pythium Root RotRhizoctonia Fungus

Fusarium (root rot)

Verticillium Wilt Phytophthora Root Rot Sclerotinia Stem Rot

Botrytis (gray mold)Powdery Mildew*

MustGrow’s natural biologics provide treatment of these pests and diseases

10

Nematodes

Capital Structure

Debt has no maturity; no interest payable; no scheduled principal payments. Due upon change of control of MustGrow and/or certain revenue milestones. 11

CSE: MGRO / OTC: MGROF / FRA: 0C0

Corey Giasson, President & CEO coreyg@mustgrow.ca

p: 306-717-1128

Thank you

Colin Bletsky, COO colinb@mustgrow.ca

p: 306-241-6095

12